Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhaled antibiotics in the treatment of non-cystic fibrosis bronchiectasis: clinical and drug delivery perspectives
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 13, Issue 1, Pages 7-22
Publisher
Informa Healthcare
Online
2015-11-14
DOI
10.1517/17425247.2015.1078309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models
- (2015) Marius Hittinger et al. ADVANCED DRUG DELIVERY REVIEWS
- Inhaled antimicrobial therapy – Barriers to effective treatment
- (2015) Jeffry Weers ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy
- (2015) Jatinder Kaur Mukker et al. ADVANCED DRUG DELIVERY REVIEWS
- Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead
- (2015) Tony Velkov et al. ADVANCED DRUG DELIVERY REVIEWS
- A novel inhaled multi-pronged attack against respiratory bacteria
- (2015) Sie Huey Lee et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Delivery of antibiotics with polymeric particles
- (2014) Meng-Hua Xiong et al. ADVANCED DRUG DELIVERY REVIEWS
- Delivery strategies for sustained drug release in the lungs
- (2014) Cristina Loira-Pastoriza et al. ADVANCED DRUG DELIVERY REVIEWS
- Nebulized Colistin for Non–Cystic Fibrosis Bronchiectasis: Déjà Vu All Over Again?
- (2014) Mark L. Metersky et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhaled Colistin in Patients with Bronchiectasis and ChronicPseudomonas aeruginosaInfection
- (2014) Charles S. Haworth et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Bronchiectasis Severity Index. An International Derivation and Validation Study
- (2014) James D. Chalmers et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Inhaled Colistin in Elderly Patients With Non-Cystic Fibrosis Bronchiectasis and Chronic Pseudomonas aeruginosa (PA) Bronchial Infection
- (2014) Eva Tabernero et al. CHEST
- Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
- (2014) A. M. Brodt et al. EUROPEAN RESPIRATORY JOURNAL
- Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis
- (2014) Marta Pastor et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)
- (2014) M.J. Harrison et al. Journal of Cystic Fibrosis
- Efficacy of Ciprofloxacin-Clarithromycin Combination Against Drug-Resistant Pseudomonas aeruginosa Mature Biofilm Using In Vitro Experimental Model
- (2014) Walid Elkhatib et al. Microbial Drug Resistance
- Aerosolized Antibiotics for Non-Cystic Fibrosis Bronchiectasis
- (2014) Bruce K. Rubin et al. RESPIRATION
- Lung clearance index in adults with non-cystic fibrosis bronchiectasis
- (2014) Sherif Gonem et al. RESPIRATORY RESEARCH
- Long-term macrolides for non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis
- (2014) Qibiao Wu et al. RESPIROLOGY
- Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores
- (2014) Alexandra L Quittner et al. THORAX
- Treatment adherence and health outcomes in patients with bronchiectasis
- (2014) Amanda R McCullough et al. BMC Pulmonary Medicine
- Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials
- (2014) Alan F Barker et al. Lancet Respiratory Medicine
- Defining severity in non-cystic fibrosis bronchiectasis
- (2014) Lucy Poppelwell et al. Expert Review of Respiratory Medicine
- Non–Cystic Fibrosis Bronchiectasis
- (2013) Pamela J. McShane et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prognostic Value of Bronchiectasis in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease
- (2013) Miguel-Angel Martínez-García et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy and Safety of Liposomal Clarithromycin and Its Effect on Pseudomonas aeruginosa Virulence Factors
- (2013) Mai Alhajlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
- (2013) Heino Stass et al. CLINICAL DRUG INVESTIGATION
- Tolerability and Pharmacokinetic Properties of Ciprofloxacin Dry Powder for Inhalation in Patients With Cystic Fibrosis: A Phase I, Randomized, Dose-Escalation Study
- (2013) Heino Stass et al. CLINICAL THERAPEUTICS
- Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis
- (2013) Mehdi Mirsaeidi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols
- (2013) Chun-Woong Park et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Physicochemical Aspects of the Coformulation of Colistin and Azithromycin Using Liposomes for Combination Antibiotic Therapies
- (2013) Stephanie J. Wallace et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- New Co-Spray-Dried Tobramycin Nanoparticles-Clarithromycin Inhaled Powder Systems for Lung Infection Therapy in Cystic Fibrosis Patients
- (2013) Gabrielle Pilcer et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Development of a nano–micro carrier system for sustained pulmonary delivery of clarithromycin
- (2013) P. Hadipour Moghaddam et al. POWDER TECHNOLOGY
- Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial
- (2013) David J Serisier et al. THORAX
- Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition
- (2013) Geraint B Rogers et al. THORAX
- Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non–Cystic Fibrosis Bronchiectasis
- (2012) James D. Chalmers et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Challenges with current inhaled treatments for chronicPseudomonas aeruginosainfection in patients with cystic fibrosis
- (2012) Peter Greally et al. CURRENT MEDICAL RESEARCH AND OPINION
- Synergistic combination dry powders for inhaled antimicrobial therapy: Formulation, characterization and in vitro evaluation
- (2012) Sie Huey Lee et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: a phase II randomised study
- (2012) Robert Wilson et al. EUROPEAN RESPIRATORY JOURNAL
- Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells
- (2012) R.P. Aquino et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Aerosol-Based Efficient Delivery of Clarithromycin, a Macrolide Antimicrobial Agent, to Lung Epithelial Lining Fluid and Alveolar Macrophages for Treatment of Respiratory Infections
- (2012) Kohei Togami et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Dose Emission Characteristics of Placebo PulmoSphere® Particles Are Unaffected by a Subject's Inhalation Maneuver
- (2012) Jeffry Weers et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises
- (2012) Francesca Ungaro et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Therapeutic Liposomal Dry Powder Inhalation Aerosols for Targeted Lung Delivery
- (2012) Lauren Willis et al. LUNG
- Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis
- (2012) James D. Chalmers et al. MOLECULAR IMMUNOLOGY
- Liposomal Nanoparticles Control the Uptake of Ciprofloxacin Across Respiratory Epithelia
- (2012) Hui Xin Ong et al. PHARMACEUTICAL RESEARCH
- Research priorities in bronchiectasis
- (2012) Anthony De Soyza et al. THORAX
- Safety, efficacy and convenience of colistimethate sodium dry powder for inhalation (Colobreathe DPI) in patients with cystic fibrosis: a randomised study
- (2012) Antje Schuster et al. THORAX
- Levofloxacin Inhalation Solution (MP-376) in Patients with Cystic Fibrosis withPseudomonas aeruginosa
- (2011) David E. Geller et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis withPseudomonasAirway Infection
- (2011) Bruce C. Trapnell et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Efficacy and Safety of Budesonide-Formoterol in Non-Cystic Fibrosis Bronchiectasis
- (2011) Miguel Ángel Martínez-García et al. CHEST
- Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: Modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers
- (2011) Francesca Ungaro et al. JOURNAL OF CONTROLLED RELEASE
- Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditions
- (2011) Gerard McCaughey et al. Journal of Cystic Fibrosis
- Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis
- (2011) Laura White et al. RESPIRATORY MEDICINE
- A Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis
- (2010) Maeve P. Murray et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficacy of the Combination of Tobramycin and a Macrolide in an In Vitro Pseudomonas aeruginosa Mature Biofilm Model
- (2010) M. Tre-Hardy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
- (2010) S. Kanoh et al. CLINICAL MICROBIOLOGY REVIEWS
- Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods
- (2010) Wean Sin Cheow et al. COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
- Controlled release antibiotics for dry powder lung delivery
- (2010) Handoko Adi et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections
- (2010) Kohei Togami et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Co-spray-dried mannitol–ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease
- (2010) Handoko Adi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- High azithromycin loading powders for inhalation and their in vivo evaluation in rats
- (2010) Yu Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- British Thoracic Society guideline for non-CFbronchiectasis
- (2010) M. C. Pasteur et al. THORAX
- Qualitative Analysis of High-Resolution CT Scans in Severe Asthma
- (2009) Sumit Gupta et al. CHEST
- Recent advances in liposomal dry powder formulations: preparation and evaluation
- (2009) Ambikanandan Misra et al. Expert Opinion on Drug Delivery
- Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
- (2009) D. L. MacLeod et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Inhaled Liposomes–Current Strategies and Future Challenges
- (2008) Maria Manuela Gaspar et al. Journal of Biomedical Nanotechnology
- Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains
- (2007) Misagh Alipour et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Cospray Dried Antibiotics for Dry Powder Lung Delivery
- (2007) Handoko Adi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started